Joint ARCS/BFS guidelines and addendum
The ARCS/BFS COVID Group met yesterday to consider the Joint Guidelines. We have agreed an
addendum to version 3 taking into account the likely discussions with patients around
vaccination and fertility treatment in light of the Joint Committee on Vaccination and
Immunisation priority advice relating to the Pfizer - BioNTech vaccine published on
The addendum may be updated as advice changes and incorporated into future versions
of the guidance. On behalf of the Executive Committees of both societies
the Group invite our members to comment on the Guidelines and in particular
any new areas of concern or practice which you feel should be included or
addressed differently. In particular we are interested in your experience
of so-called long COVID - in terms of either repeat screening or perhaps more
importantly any observed effects in your patients, male or female.
Review the addendum here.
Thank you as ever for your support and help in this.
We wish you well for the Festive period however altered that might be
for you - health and happiness to those around you.
British Fertility Society